Toll Free: 1-888-928-9744
Published: Nov, 2014 | Pages:
27 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
United Biomedical, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'United Biomedical, Inc. - Product Pipeline Review - 2014', provides an overview of the United Biomedical, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of United Biomedical, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of United Biomedical, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of United Biomedical, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the United Biomedical, Inc.'s pipeline products Reasons to buy - Evaluate United Biomedical, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of United Biomedical, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the United Biomedical, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of United Biomedical, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of United Biomedical, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of United Biomedical, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 United Biomedical, Inc. Snapshot 5 United Biomedical, Inc. Overview 5 Key Information 5 Key Facts 5 United Biomedical, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 United Biomedical, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 United Biomedical, Inc. - Pipeline Products Glance 10 United Biomedical, Inc. - Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 United Biomedical, Inc. - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 United Biomedical, Inc. - Drug Profiles 12 UB-311 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 UB-421 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 HIV (gp120) vaccine 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 HIV vaccine 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Synthetic Peptide for Undisclosed Indication 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 TW-01003 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Vaccine for Allergy 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 United Biomedical, Inc. - Pipeline Analysis 19 United Biomedical, Inc. - Pipeline Products by Target 19 United Biomedical, Inc. - Pipeline Products by Route of Administration 20 United Biomedical, Inc. - Pipeline Products by Molecule Type 21 United Biomedical, Inc. - Pipeline Products by Mechanism of Action 22 United Biomedical, Inc. - Recent Pipeline Updates 23 United Biomedical, Inc. - Dormant Projects 24 United Biomedical, Inc. - Locations And Subsidiaries 25 Head Office 25 Other Locations & Subsidiaries 25 Appendix 26 Methodology 26 Coverage 26 Secondary Research 26 Primary Research 26 Expert Panel Validation 26 Contact Us 27 Disclaimer 27
List of Tables United Biomedical, Inc., Key Information 5 United Biomedical, Inc., Key Facts 5 United Biomedical, Inc. - Pipeline by Indication, 2014 7 United Biomedical, Inc. - Pipeline by Stage of Development, 2014 8 United Biomedical, Inc. - Monotherapy Products in Pipeline, 2014 9 United Biomedical, Inc. - Phase II, 2014 10 United Biomedical, Inc. - Preclinical, 2014 11 United Biomedical, Inc. - Pipeline by Target, 2014 19 United Biomedical, Inc. - Pipeline by Route of Administration, 2014 20 United Biomedical, Inc. - Pipeline by Molecule Type, 2014 21 United Biomedical, Inc. - Pipeline Products by Mechanism of Action, 2014 22 United Biomedical, Inc. - Recent Pipeline Updates, 2014 23 United Biomedical, Inc. - Dormant Developmental Projects,2014 24 United Biomedical, Inc., Subsidiaries 25
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.